NANO-ALL

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNANO-ALL
Drug Alias NamesiRNA therapy (Nanovalent/Children's Hospital of Los Angeles)NANO-ALL
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTransferrins modulators
TargetsTransferrins
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanovalent Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChildren'S Hospital Los AngelesNanovalent Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A